RyuvidineSETD8 inhibitor; also CDK4 inhibitor CAS# 265312-55-8 |
- I-BET-762
Catalog No.:BCC4474
CAS No.:1260907-17-2
- Bromodomain Inhibitor, (+)-JQ1
Catalog No.:BCC1132
CAS No.:1268524-70-4
- I-BET151 (GSK1210151A)
Catalog No.:BCC4476
CAS No.:1300031-49-5
- GSK1324726A
Catalog No.:BCC4038
CAS No.:1300031-52-0
- PFI-1 (PF-6405761)
Catalog No.:BCC2225
CAS No.:1403764-72-6
Quality Control & MSDS
3D structure
Package In Stock
Number of papers citing our products
| Cas No. | 265312-55-8 | SDF | Download SDF |
| PubChem ID | 481747 | Appearance | Powder |
| Formula | C15H12N2O2S | M.Wt | 284.33 |
| Type of Compound | N/A | Storage | Desiccate at -20°C |
| Solubility | Soluble to 20 mM in DMSO and to 5 mM in ethanol | ||
| Chemical Name | 2-methyl-5-(4-methylanilino)-1,3-benzothiazole-4,7-dione | ||
| SMILES | CC1=CC=C(C=C1)NC2=CC(=O)C3=C(C2=O)N=C(S3)C | ||
| Standard InChIKey | HFPLHASLIOXVGS-UHFFFAOYSA-N | ||
| Standard InChI | InChI=1S/C15H12N2O2S/c1-8-3-5-10(6-4-8)17-11-7-12(18)15-13(14(11)19)16-9(2)20-15/h3-7,17H,1-2H3 | ||
| General tips | For obtaining a higher solubility , please warm the tube at 37 ℃ and shake it in the ultrasonic bath for a while.Stock solution can be stored below -20℃ for several months. We recommend that you prepare and use the solution on the same day. However, if the test schedule requires, the stock solutions can be prepared in advance, and the stock solution must be sealed and stored below -20℃. In general, the stock solution can be kept for several months. Before use, we recommend that you leave the vial at room temperature for at least an hour before opening it. |
||
| About Packaging | 1. The packaging of the product may be reversed during transportation, cause the high purity compounds to adhere to the neck or cap of the vial.Take the vail out of its packaging and shake gently until the compounds fall to the bottom of the vial. 2. For liquid products, please centrifuge at 500xg to gather the liquid to the bottom of the vial. 3. Try to avoid loss or contamination during the experiment. |
||
| Shipping Condition | Packaging according to customer requirements(5mg, 10mg, 20mg and more). Ship via FedEx, DHL, UPS, EMS or other couriers with RT, or blue ice upon request. | ||
| Description | Inhibitor of SETD8 protein lysine methyltransferase (PKMT) (IC50 = 0.5 μM); suppresses H4K20 monomethylation in vitro. Also inhibits cyclin-dependent kinase (CDK) 4 (IC50 = 6.0 μM at CDK4/cyclin D1). Induces S phase accumulation in HEK293T cells. Cytotoxic against a range of human cancer cells. |
Ryuvidine Dilution Calculator
Ryuvidine Molarity Calculator
| 1 mg | 5 mg | 10 mg | 20 mg | 25 mg | |
| 1 mM | 3.517 mL | 17.5852 mL | 35.1704 mL | 70.3408 mL | 87.926 mL |
| 5 mM | 0.7034 mL | 3.517 mL | 7.0341 mL | 14.0682 mL | 17.5852 mL |
| 10 mM | 0.3517 mL | 1.7585 mL | 3.517 mL | 7.0341 mL | 8.7926 mL |
| 50 mM | 0.0703 mL | 0.3517 mL | 0.7034 mL | 1.4068 mL | 1.7585 mL |
| 100 mM | 0.0352 mL | 0.1759 mL | 0.3517 mL | 0.7034 mL | 0.8793 mL |
| * Note: If you are in the process of experiment, it's necessary to make the dilution ratios of the samples. The dilution data above is only for reference. Normally, it's can get a better solubility within lower of Concentrations. | |||||
Calcutta University
University of Minnesota
University of Maryland School of Medicine
University of Illinois at Chicago
The Ohio State University
University of Zurich
Harvard University
Colorado State University
Auburn University
Yale University
Worcester Polytechnic Institute
Washington State University
Stanford University
University of Leipzig
Universidade da Beira Interior
The Institute of Cancer Research
Heidelberg University
University of Amsterdam
University of Auckland
TsingHua University
The University of Michigan
Miami University
DRURY University
Jilin University
Fudan University
Wuhan University
Sun Yat-sen University
Universite de Paris
Deemed University
Auckland University
The University of Tokyo
Korea University
- GW 7647
Catalog No.:BCC7150
CAS No.:265129-71-3
- Fosaprepitant dimeglumine salt
Catalog No.:BCC4954
CAS No.:265121-04-8
- Taiwanhomoflavone A
Catalog No.:BCN6853
CAS No.:265120-00-1
- N-[Bis(methylthio)methylene]- p-toluenesulfonamide
Catalog No.:BCC9069
CAS No.:2651-15-2
- Methyleugenolglycol
Catalog No.:BCN6562
CAS No.:26509-45-5
- Z-Gln-OH
Catalog No.:BCC2783
CAS No.:2650-64-8
- Nandrolone laurate
Catalog No.:BCC9088
CAS No.:26490-31-3
- Clovanediol diacetate
Catalog No.:BCN5144
CAS No.:2649-68-5
- Clovanediol
Catalog No.:BCN5143
CAS No.:2649-64-1
- Cyclo(D-Phe-L-Pro)
Catalog No.:BCN4011
CAS No.:26488-24-4
- 6-Deoxyisojacareubin
Catalog No.:BCN7723
CAS No.:26486-92-0
- Catharanthine Tartrate
Catalog No.:BCN2462
CAS No.:2648-21-5
- (-)-Hinokinin
Catalog No.:BCN3227
CAS No.:26543-89-5
- Apiin
Catalog No.:BCN2311
CAS No.:26544-34-3
- 8-Phenyloctanoic acid
Catalog No.:BCC8790
CAS No.:26547-51-3
- 2,3-Dihydroxy-12-oleanen-28-oic acid
Catalog No.:BCN5145
CAS No.:26563-68-8
- 3-Hydroxycatalponol
Catalog No.:BCN5146
CAS No.:265644-24-4
- Z-D-Glu-OMe
Catalog No.:BCC2773
CAS No.:26566-11-0
- Alisol C monoacetate
Catalog No.:BCN2345
CAS No.:26575-93-9
- Alisol B 23-acetate
Catalog No.:BCN1243
CAS No.:26575-95-1
- 5-Acetoacetlamino benzimdazolone
Catalog No.:BCC8725
CAS No.:26576-46-5
- Harmalacidine
Catalog No.:BCN8033
CAS No.:26579-69-1
- Dehydrocrenatine
Catalog No.:BCN5147
CAS No.:26585-13-7
- Crenatine
Catalog No.:BCN5148
CAS No.:26585-14-8
A high through-put screen for small molecules modulating MCM2 phosphorylation identifies Ryuvidine as an inducer of the DNA damage response.[Pubmed:24902048]
PLoS One. 2014 Jun 5;9(6):e98891.
DNA replication is an essential process for cell division and as such it is a process that is directly targeted by several anticancer drugs. CDC7 plays an essential role in the activation of replication origins and has recently been proposed as a novel target for drug discovery. The MCM DNA helicase complex (MCM2-7) is a key target of the CDC7 kinase, and MCM phosphorylation status at specific sites is a reliable biomarker of CDC7 cellular activity. In this work we describe a cell-based assay that utilizes the "In Cell Western Technique" (ICW) to identify compounds that affect cellular CDC7 activity. By screening a library of approved drugs and kinase inhibitors we found several compounds that can affect CDC7-dependent phosphorylation of MCM2 in HeLa cells. Among these, Mitoxantrone, a topoisomerase inhibitor, and Ryuvidine, previously described as a CDK4 inhibitor, cause a reduction in phosphorylated MCM2 levels and a sudden blockade of DNA synthesis that is accompanied by an ATM-dependent checkpoint response. This study sheds light on the previously observed cytotoxity of Ryuvidine, strongly suggesting that it is related to its effect of causing DNA damage.
Small-molecule inhibitors of SETD8 with cellular activity.[Pubmed:25137013]
ACS Chem Biol. 2014 Nov 21;9(11):2471-8.
SETD8/SET8/Pr-SET7/KMT5A is the sole protein lysine methyltransferase (PKMT) known to monomethylate lysine 20 of histone H4 in vivo. SETD8's methyltransferase activity has been implicated in many essential cellular processes including DNA replication, DNA damage response, transcription modulation, and cell cycle regulation. Developing SETD8 inhibitors with cellular activity is a key step toward elucidating the diverse roles of SETD8 via convenient pharmacological perturbation. From the hits of a prior high throughput screen (HTS), SPS8I1-3 (NSC663284, BVT948, and Ryuvidine) were validated as potent SETD8 inhibitors. These compounds contain different structural motifs and inhibit SETD8 via distinct modes. More importantly, these compounds show cellular activity by suppressing the H4K20me1 mark of SETD8 and recapitulate characteristic S/G2/M-phase cell cycle defects as observed for RNAi-mediated SETD8 knockdown. The commonality of SPS8I1-3 against SETD8, together with their distinct structures and mechanisms for SETD8 inhibition, argues for the collective application of these compounds as SETD8 inhibitors.
5-Arylamino-2-methyl-4,7-dioxobenzothiazoles as inhibitors of cyclin-dependent kinase 4 and cytotoxic agents.[Pubmed:10743948]
Bioorg Med Chem Lett. 2000 Mar 6;10(5):461-4.
5-Arylamino-2-methyl-4,7-dioxobenzothiazoles were synthesized as inhibitors of cyclin-dependent kinase 4 (CDK4) and cytotoxic agents. Most of the 4,7-dioxobenzothiazoles exhibited selective inhibitory activities for the CDK4 and cytotoxic potential against human cancer cell lines.
